title: Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.
abstract: The B-cell chronic lymphocytic leukemia (CLL)/lymphoma 11B gene (BCL11B) encodes a Krüppel-like zinc-finger protein, which plays a crucial role in thymopoiesis and has been associated with hematopoietic malignancies. It was hypothesized that BCL11B may act as a tumor-suppressor gene, but its precise function has not yet been elucidated. Here, we demonstrate that the survival of human T-cell leukemia and lymphoma cell lines is critically dependent on Bcl11b. Suppression of Bcl11b by RNA interference selectively induced apoptosis in transformed T cells whereas normal mature T cells remained unaffected. The apoptosis was effected by simultaneous activation of death receptor-mediated and intrinsic apoptotic pathways, most likely as a result of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) upregulation and suppression of the Bcl-xL antiapoptotic protein. Our data indicate an antiapoptotic function of Bcl11b. The resistance of normal mature T lymphocytes to Bcl11b suppression-induced apoptosis and restricted expression pattern make it an attractive therapeutic target in T-cell malignancies.
authors.affiliation: Clinic for Internal Medicine C, University of Greifswald, Greifswald, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Grabarczyk
authors.forename: G K
authors.initials: GK
authors.lastname: Przybylski
authors.forename: M
authors.initials: M
authors.lastname: Depke
authors.forename: U
authors.initials: U
authors.lastname: Völker
authors.forename: J
authors.initials: J
authors.lastname: Bahr
authors.forename: K
authors.initials: K
authors.lastname: Assmus
authors.forename: B M
authors.initials: BM
authors.lastname: Bröker
authors.forename: R
authors.initials: R
authors.lastname: Walther
authors.forename: C A
authors.initials: CA
authors.lastname: Schmidt
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D015153:Blotting, Western; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000037:antagonists & inhibitors*; D005434:Flow Cytometry; D006801:Humans; D019169:Jurkat Cells; D015458:Leukemia, T-Cell / Q000235:genetics / Q000378:metabolism*; D008223:Lymphoma / Q000235:genetics / Q000378:metabolism*; D034622:RNA Interference; D012333:RNA, Messenger / Q000032:analysis; D034741:RNA, Small Interfering; D012097:Repressor Proteins / Q000037:antagonists & inhibitors*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000378:metabolism* / Q000473:pathology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism; D014158:Transcription, Genetic; D025521:Tumor Suppressor Proteins / Q000037:antagonists & inhibitors*; D051020:bcl-X Protein / Q000378:metabolism
chemical_list: C479740:BCL11B protein, human; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D012097:Repressor Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D025521:Tumor Suppressor Proteins; D051020:bcl-X Protein